v3.26.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Operating Activities:    
Net loss $ (6,159) $ (4,140)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 819 931
Provision for credit losses 5 0
Stock-based compensation 212 504
Non-cash lease costs 207 109
Non-cash interest 99 9
Changes in operating assets and liabilities:    
Accounts receivable (916) 66
Prepaid expenses and other assets (134) (1,442)
Accounts payable and accrued expenses 393 (302)
Operating lease liabilities (228) (230)
Deferred revenue 291 1,245
Net cash used in operating activities (5,411) (3,250)
Investing Activities:    
Purchases of United States (“U.S.”) treasury securities 0 (3,749)
Purchases of property and equipment (55) (725)
Capitalized software development (587) (676)
Cash paid for acquisition, net of cash acquired (356) 0
Net cash used in investing activities (998) (5,150)
Financing Activities:    
Proceeds from public stock offering net of fees (6) (97)
Proceeds from notes payable 3,349 0
Cash paid for debt issuance costs (178) 0
Proceeds from registered direct offering, net of fees 0 7,026
Proceeds from stock subscription receivable 0 1,542
Proceeds related to the issuance of common stock under stock purchase plan 12 10
Reduction of finance lease liabilities (69) (243)
Cash paid for taxes withheld on net settled restricted stock unit vesting (141) 0
Net cash provided by financing activities 2,967 8,238
Net decrease in cash and cash equivalents (3,442) (162)
Cash and cash equivalents at beginning of period 3,624 4,851
Cash and cash equivalents at end of period 182 4,689
SUPPLEMENTAL DISCLOSURE OF CASH FLOW ACTIVITIES:    
Cash paid for interest 0 5
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Capitalized asset and capitalized software included in accounts payable 0 89
Common stock issued to reduce notes payable 0 537
Modification of right-of-use finance lease 0 (18)
Common stock issued for acquisition $ 1,590 $ 0